Physical Activity and Fatigue in Early Multiple Sclerosis (MS) (BEGIN)

Bayer

Status: Completed

Conditions: Multiple Sclerosis

Treatments: Drug: Interferon beta-1b (Betaseron, BAY86-5046)

Study type: Observational

Funder types: Industry

Identifiers

NCT00882453

310721 (Other Identifier)

BF0601 (Other Identifier)

13853

Details and patient eligibility

About

The purpose of this observational study is to obtain a survey on physical activity in patients who for the first time have experienced symptoms which indicate a high risk for developing multiple sclerosis (MS) and in patients with recently diagnosed MS, and to obtain information on factors potentially influencing the patients' level of activity.

Enrollment: 1,739 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Multiple sclerosis diagnosed within the last 12 months
• Clinically isolated Syndrome (CIS), under Interferon-beta-1b treatment

Trial design

1,739 participants in 1 patient group

Group 1

Treatment:

Drug: Interferon beta-1b (Betaseron, BAY86-5046)